FAMHP organises two information sessions to provide all sponsors and applicants for clinical trials with as much information as possible about the new Regulation. BeCRO is actively involved in the organisation of these workshops. The first information session took place on 23 September 2021.During this session, an update was given on the different aspects of the […]
On the 15th October 2019, the European Commission (EC) published a set of documents applicable to clinical trials that will be authorised under Regulation EU No 536/2014, once it becomes applicable. Please see under the following link EudraLex – Volume 10 – Clinical trials guidelines : https://ec.europa.eu/health/documents/eudralex/vol-10_en#fragment1
Read More "Clinical trials guidelines"A dedicated working group has prepared a new template for the Informed Consent Form (ICF) for interventional clinical trials with an investigational medicinal product on adult patients. The working group consisted of representatives of BAREC (Belgian Association of Research Ethics Committees), pharma.be (the Belgian association of the innovative (bio)pharmaceutical industry) and patient organizations, and was […]
Read More "PUBLICATION of ICF templates for interventional trials on adult patients"Please find hereby a video from our President.
Read More "BeCRO is attracting investors in the Health & Life Sciences to do business in Belgium"The BeCRO board is looking forward to celebrate its 10th anniversary together with ACRON celebrating its 25th anniversary at the EUCROF conference in 2020! ORGANIZERS: EUCROF AFCRO BECRO DATE: FEBRUARY 10, 2020 – FEBRUARY 11, 2020
Read More "SAVE THE DATE! JOINED EUCROF, ACRON & BECRO 5TH EUROPEAN CONFERENCE ON CLINICAL RESEARCH"Webinar: Doing More with Data: Data Anonymization and Pseudonymisation under the GDPR on April 17, 2019 Date & Time: 17 April 2019 from 3:30 PM to 5:00 PM (CET) Attendance Fee: € 90,- for EUCROF non-members € 60,- for EUCROF members using the code DATA0417 Register here
Read More "Webinar: Doing More with Data: Data Anonymization and Pseudonymisation under the GDPR on April 17, 2019"SAVE THE DATES BLOCKCHAIN IN CLINICAL TRIALS – HYPE OR REALITY ? * June 21, 2019 BLOCKCHAIN IN CLINICAL TRIALS – HYPE OR REALITY? Blockchain in Clinical Trials- How and Why Blockchain and Distributed Ledger Technologies (DLTs) are new disruptive approaches in the Clinical Trials Industry? For the last 2 years, multiple initiatives are moving […]
Read More "BLOCKCHAIN IN CLINICAL TRIALS – HYPE OR REALITY?"GDPR, all CROs and entreprises are getting compliant The new EU regulation on General Data Protection is to be applied as of May 25, 2018. Read more here and make sure your CRO is compliant : GDPR regulation
Read More "GDPR, all CROs and entreprises are getting compliant"Surfing the innovation wave, an interview with the Director General EFPIA Influential industry body, EFPIA, has for years helped pharma improve transparency and repair its long-tainted reputation. Tackling key issues such as innovation, patient access and collaborative R&D, Eyeforpharma caught up with the new Director General, Nathalie Moll, to discover where their focus is for […]
Read More "Surfing the innovation wave, an interview with the Director General EFPIA"Direct to Patient (D2P) shipment for Clinical Trials – Survey Dear Sponsor, CRO, Investigator or Patient, Within Europe and more specifically within Belgium, Direct To Patient (D2P) shipments have limitations within the current regulatory framework. Considering the growing enthusiasm of pharma companies, investigators and patients performing D2P shipments in the US, we need to investigate […]
Read More "Direct to Patient (D2P) shipment for Clinical Trials – Survey"Virtual Clinical Trials and Direct to Patient Shipments BeCRO has set up and coordinates, with the cabinet of Maggie De Block, FAMHP, FlandersBio, BioWin, Lifetech Brussels, BRAS and several top Pharma companies, a lobbying group on “Virtual Clinical trials and Direct to Patient Shipments”. This working group has conducted a survey on Direct to Patient […]
Read More "Virtual Clinical Trials and Direct to Patient Shipments"